FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4247201730> ?p ?o ?g. }

• W4247201730 endingPage "378" @default.
• W4247201730 startingPage "371" @default.
• W4247201730 abstract "Lipoatrophy is one of the most feared complications associated with the use of nucleoside or nucleotide reverse transcriptase inhibitors (N[t]RTIs). We aimed to assess soft-tissue changes in participants with HIV who had virological failure of a first-line antiretroviral (ART) regimen containing a non-nucleoside reverse transcriptase inhibitor plus two N(t)RTIs and were randomly assigned to receive a second-line regimen containing a boosted protease inhibitor given with either N(t)RTIs or raltegravir.Of the 37 sites that participated in the randomised, open-label, non-inferiority SECOND-LINE study, eight sites from five countries (Argentina, India, Malaysia, South Africa, and Thailand) participated in the body composition substudy. All sites had a dual energy x-ray absorptiometry (DXA) scanner and all participants enrolled in SECOND-LINE were eligible for inclusion in the substudy. Participants were randomly assigned (1:1), via a computer-generated allocation schedule, to receive either ritonavir-boosted lopinavir plus raltegravir (raltegravir group) or ritonavir-boosted lopinavir plus two or three N(t)RTIs (N[t]RTI group). Randomisation was stratified by site and screening HIV-1 RNA. Participants and investigators were not masked to group assignment, but allocation was concealed until after interventions were assigned. DXA scans were done at weeks 0, 48, and 96. The primary endpoint was mean percentage and absolute change in peripheral limb fat from baseline to week 96. We did intention-to-treat analyses of available data. This substudy is registered with ClinicalTrials.gov, number NCT01513122.Between Aug 1, 2010, and July 10, 2011, we recruited 211 participants into the substudy. The intention-to-treat population comprised 102 participants in the N(t)RTI group and 108 participants in the raltegravir group, of whom 91 and 105 participants, respectively, reached 96 weeks. Mean percentage change in limb fat from baseline to week 96 was 16·8% (SD 32·6) in the N(t)RTI group and 28·0% (37·6) in the raltegravir group (mean difference 10·2%, 95% CI 0·1–20·4; p=0·048). Mean absolute change was 1·04 kg (SD 2·29) in the N(t)RTI group and 1·81 kg (2·50) in the raltegravir group (mean difference 0·6, 95% CI −0·1 to 1·3; p=0·10).Our findings suggest that for people with virological failure of a first-line regimen containing efavirenz plus tenofovir and lamivudine or emtricitabine, the WHO-recommended switch to a ritonavir-boosted protease inhibitor plus zidovudine (a thymidine analogue nucleoside reverse transcriptase inhibitor) and lamivudine might come at the cost of peripheral lipoatrophy. Further study could help to define specific groups of people who might benefit from a switch to an N(t)RTI-sparing second-line ART regimen.The Kirby Institute and the Australian National Health and Medical Research Council." @default.
• W4247201730 created "2022-05-12" @default.
• W4247201730 creator A5034889024 @default.
• W4247201730 creator A5067618202 @default.
• W4247201730 date "1983-08-01" @default.
• W4247201730 modified "2023-09-26" @default.
• W4247201730 title "Atelectasis" @default.
• W4247201730 cites W1537468106 @default.
• W4247201730 cites W1969966410 @default.
• W4247201730 cites W1979375895 @default.
• W4247201730 cites W1994559885 @default.
• W4247201730 cites W1994654986 @default.
• W4247201730 cites W2001990965 @default.
• W4247201730 cites W2009020759 @default.
• W4247201730 cites W2020959878 @default.
• W4247201730 cites W2060354182 @default.
• W4247201730 cites W2076556693 @default.
• W4247201730 cites W2082918597 @default.
• W4247201730 cites W2090870582 @default.
• W4247201730 cites W2100650314 @default.
• W4247201730 cites W2114828471 @default.
• W4247201730 cites W2117302977 @default.
• W4247201730 cites W2143388999 @default.
• W4247201730 cites W2145198579 @default.
• W4247201730 cites W2162336557 @default.
• W4247201730 cites W2276124065 @default.
• W4247201730 cites W2404490502 @default.
• W4247201730 cites W2419439645 @default.
• W4247201730 doi "https://doi.org/10.1016/s0733-8627(20)30794-x" @default.
• W4247201730 hasPublicationYear "1983" @default.
• W4247201730 type Work @default.
• W4247201730 citedByCount "4" @default.
• W4247201730 countsByYear W42472017302016 @default.
• W4247201730 countsByYear W42472017302021 @default.
• W4247201730 crossrefType "journal-article" @default.
• W4247201730 hasAuthorship W4247201730A5034889024 @default.
• W4247201730 hasAuthorship W4247201730A5067618202 @default.
• W4247201730 hasConcept C126322002 @default.
• W4247201730 hasConcept C142462285 @default.
• W4247201730 hasConcept C159047783 @default.
• W4247201730 hasConcept C2777182164 @default.
• W4247201730 hasConcept C2779298103 @default.
• W4247201730 hasConcept C2779546735 @default.
• W4247201730 hasConcept C2780404665 @default.
• W4247201730 hasConcept C2781413609 @default.
• W4247201730 hasConcept C2993143319 @default.
• W4247201730 hasConcept C3013748606 @default.
• W4247201730 hasConcept C71924100 @default.
• W4247201730 hasConceptScore W4247201730C126322002 @default.
• W4247201730 hasConceptScore W4247201730C142462285 @default.
• W4247201730 hasConceptScore W4247201730C159047783 @default.
• W4247201730 hasConceptScore W4247201730C2777182164 @default.
• W4247201730 hasConceptScore W4247201730C2779298103 @default.
• W4247201730 hasConceptScore W4247201730C2779546735 @default.
• W4247201730 hasConceptScore W4247201730C2780404665 @default.
• W4247201730 hasConceptScore W4247201730C2781413609 @default.
• W4247201730 hasConceptScore W4247201730C2993143319 @default.
• W4247201730 hasConceptScore W4247201730C3013748606 @default.
• W4247201730 hasConceptScore W4247201730C71924100 @default.
• W4247201730 hasIssue "2" @default.
• W4247201730 hasLocation W42472017301 @default.
• W4247201730 hasOpenAccess W4247201730 @default.
• W4247201730 hasPrimaryLocation W42472017301 @default.
• W4247201730 hasRelatedWork W1972379179 @default.
• W4247201730 hasRelatedWork W1984717040 @default.
• W4247201730 hasRelatedWork W2053468006 @default.
• W4247201730 hasRelatedWork W2070800026 @default.
• W4247201730 hasRelatedWork W2090886797 @default.
• W4247201730 hasRelatedWork W2123055341 @default.
• W4247201730 hasRelatedWork W2547433541 @default.
• W4247201730 hasRelatedWork W2785915935 @default.
• W4247201730 hasRelatedWork W3141735964 @default.
• W4247201730 hasRelatedWork W4247789730 @default.
• W4247201730 hasVolume "1" @default.
• W4247201730 isParatext "false" @default.
• W4247201730 isRetracted "false" @default.
• W4247201730 workType "article" @default.